Weight-loss therapy in patients with obesity with endometrial intraepithelial neoplasia and uterine cancer

Gynecol Oncol. 2024 Nov:190:78-83. doi: 10.1016/j.ygyno.2024.08.003. Epub 2024 Aug 22.

Abstract

Objective: Although obesity is an important risk factor for endometrial intraepithelial neoplasia (EIN) and uterine cancer, little is known about the trends in use of weight-loss therapy for patients with obesity with EIN and uterine cancer. We examined the use of weight-loss therapy among patients with obesity with EIN and uterine cancer.

Methods: The Merative MarketScan Database was used to identify patients aged 18-70 years who were obese and diagnosed with EIN or uterine cancer. The primary treatment for EIN or uterine cancer was categorized as either primary hysterectomy or hormonal therapy. Nutrition counseling, bariatric surgeries, and weight-management medications were identified as weight-loss therapy. We analyzed trends in the use of any weight-loss therapies with Cochran-Armitage tests. A multivariable logistic regression model was developed to examine factors associated with weight-loss therapy use.

Results: Overall, 15,374 patients were identified, including 5561 (36.2%) patients with EIN and obesity, and 9813 (63.8%) patients with uterine cancer and obesity. Weight-loss therapy was utilized within 1 year after diagnosis in 480 (8.6%) patients with EIN and in 802 (8.2%) patients with uterine cancer. Use of any weight-loss therapy after diagnosis of EIN increased from 4.1% in 2009 to 12.6% in 2020 (P < .001), and the use of any weight-loss therapy after diagnosis of uterine cancer increased from 4.9% in 2009 to 11.4% in 2020 (P < .001). In a multivariable regression model, younger age and patients with high comorbidity score were associated with a higher likelihood of using any weight-loss therapy.

Conclusions: Use of weight-loss therapy has increased, however there is still a significant underuse of this adjunctive therapy in patients with obesity with EIN or uterine cancer.

Keywords: Bariatric; Endometrial cancer; Endometrial hyperplasia; Endometrial intraepithelial neoplasia; Uterine cancer; Weight loss.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Carcinoma in Situ / therapy
  • Endometrial Neoplasms* / therapy
  • Female
  • Humans
  • Middle Aged
  • Obesity* / complications
  • Obesity* / epidemiology
  • Obesity* / therapy
  • Uterine Neoplasms* / epidemiology
  • Uterine Neoplasms* / therapy
  • Weight Loss
  • Young Adult